FDA CBER Regulate Biological Products
Investment ID: 009-000318785
Overview
Program Title
FDA CBER Regulate Biological Products
Description
Ensures the safety, expediency and efficiency of the pre-market review, approval, and law compliance processes. The investment tracks biological products pre-market lifecycle, which enables reviewers to investigate all aspects of safety before approval.
Type of Program
Non-major IT Investments
Multi-Agency Category
Not Applicable